Relapsing-remitting multiple sclerosis (RRMS), secondary progressive (SP)MS and primary progressive (PP)MS patients showed higher percentages of circulating CD8(+)CD56(-)perforin(+) T cells than controls whereas only relapsing RRMS and PPMS patients showed higher perforin expression in CD8(+)CD56(-) T cells than controls. MS patients with EDSS >= 3 showed higher percentage of CD8(+)CD56(-)perforin(+) T cells than patients with EDSS <3 and controls whereas patients with EDSS <3 showed higher percentage of this T cell subpopulation than controls. Our data show that MS is characterized by a dysregulation of CD8(+)CD56(-)perforin(+) T cells that may play a role in the development of disability. (C) 2011 Elsevier B.V. All rights reserved.

Frisullo, G., Plantone, D., Marti, A., Raffaele, I., Nociti, V., Patanella, A.k., et al. (2011). Circulating CD8(+)CD56(-)perforin(+) T cells are increased in multiple sclerosis patients. JOURNAL OF NEUROIMMUNOLOGY, 240, 137-141 [10.1016/j.jneuroim.2011.09.002].

Circulating CD8(+)CD56(-)perforin(+) T cells are increased in multiple sclerosis patients

Plantone D;
2011-01-01

Abstract

Relapsing-remitting multiple sclerosis (RRMS), secondary progressive (SP)MS and primary progressive (PP)MS patients showed higher percentages of circulating CD8(+)CD56(-)perforin(+) T cells than controls whereas only relapsing RRMS and PPMS patients showed higher perforin expression in CD8(+)CD56(-) T cells than controls. MS patients with EDSS >= 3 showed higher percentage of CD8(+)CD56(-)perforin(+) T cells than patients with EDSS <3 and controls whereas patients with EDSS <3 showed higher percentage of this T cell subpopulation than controls. Our data show that MS is characterized by a dysregulation of CD8(+)CD56(-)perforin(+) T cells that may play a role in the development of disability. (C) 2011 Elsevier B.V. All rights reserved.
2011
Frisullo, G., Plantone, D., Marti, A., Raffaele, I., Nociti, V., Patanella, A.k., et al. (2011). Circulating CD8(+)CD56(-)perforin(+) T cells are increased in multiple sclerosis patients. JOURNAL OF NEUROIMMUNOLOGY, 240, 137-141 [10.1016/j.jneuroim.2011.09.002].
File in questo prodotto:
File Dimensione Formato  
Tit_1213666_8612720.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 540.4 kB
Formato Adobe PDF
540.4 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1152674